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Editorial
Serum Gamma-Glutamyltransferase
and Intima-Media Thickness: Pointing
Again to Wall/Lumen Interactions
in Atherosclerosis
Pompella A, MD, PhD1, Emdin M, MD, PhD2, Paolicchi A, MD, PhD1, and Franzini M, PhD3
Over the last decade, several epidemiology studies—including
the Framingham Heart Study1—have documented the indepen-
dent value of serum gamma-glutamyltransferase (GGT) activ-
ity in the prognostic evaluation of cardiovascular diseases.
It was observed that GGT activity is associated with overall
mortality and cardiovascular events, either in unselected popu-
lations or in patients with established coronary artery disease,
independently from potential confounders such as liver disease
and alcohol abuse.
Eroglu et al,2 in this issue of Angiology, provide an impor-
tant confirmation, insofar as they report a significant correla-
tion between serum GGT activity and another primary
atherosclerosis marker, the carotid intima-media thickness.
These observations once more point to a potential connection
between circulating GGT activity and the diseased arterial
wall. GGT activity has been shown to participate in cellular
and extracellular redox equilibria, being able to produce both
antioxidant as well as prooxidant effects depending on inter-
actions with metal ions.3 Histochemical observations have
suggested the possibility that GGT activity may actually play
a direct role in the pathogenesis of atherosclerosis and its
complications. GGT activity accumulates in intimal layers
of atherosclerotic plaques,4,5 where its participation by redox
effects in redox-sensitive processes in the progression of
lesions—chemotaxis and inflammation, proliferation of
myofibroblasts, protease/antiprotease balance—can be envi-
saged.6 However, additional studies are required to clarify the
exact origins and dynamics of serum GGT levels. The circu-
lating enzyme is thought to be mainly released from the liver
and constitutively high serum GGT has been reported in
families as an inherited autosomal dominant characteristic.7
However, the importance of genetic factors is still a matter
of debate, and the current view is that a mixture of genetic and
environmental factors may influence serum levels of GGT.7
It has even been suggested that increased serum GGT activity
may represent a link between atherosclerosis and exposure to
environmental pollutants.8 According to another view, a
source of serum GGT might be platelets: it was thus proposed
that the increased GGT activity observed in patients with
atherosclerosis may originate from increased platelet
aggregation at the site of plaques.9,10
In their present study, Eroglu et al2 discuss the possibility that
circulating GGT in patients with atherosclerosis may derive from
the vascular lesions, where GGT accumulates. The alternative
hypothesis, that GGT found in plaques may derive from the cir-
culating enzyme, is also conceivable and has recently found some
confirmation in studies aiming to compare the biochemical char-
acteristics of GGT from the 2 sources.11 Indeed, a recently pro-
posed novel analytical approach allows to separate serum GGT
into 4 distinct chromatographic fractions, of which 3 represent
aggregates of GGT with other presently unknown proteins.12 In
healthy participants, the major cardiovascular risk factors are
associated with the high molecular weight GGT fraction termed
‘‘b-GGT,’’ which is the only fraction detectable in plaques.13
Future studies will further elucidate the nature of these pro-
tein complexes and their respective significance in the patho-
genesis of atherosclerosis. Also, the relationship between
serum GGT and C-reactive protein and fasting glucose,14 as
well as other vascular diseases such as aortic valve stenosis,
needs to be investigated.15
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